|4Feb 1, 4:50 PM ET

Johns Stefanie 4

4 · Hoth Therapeutics, Inc. · Filed Feb 1, 2021

Insider Transaction Report

Form 4
Period: 2021-01-29
Johns Stefanie
Chief Scientific Officer
Transactions
  • Award

    Options

    2021-01-29+125,000125,000 total
    Exercise: $2.11From: 2021-01-29Exp: 2031-01-29Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT